Literature DB >> 29388925

Blood will out: vascular contributions to Alzheimer's disease.

Sidney Strickland.   

Abstract

The fundamental pathology in Alzheimer's disease (AD) is neuronal dysfunction leading to cognitive impairment. The amyloid-β peptide (Aβ), derived from amyloid precursor protein, is one driver of AD, but how it leads to neuronal dysfunction is not established. In this Review, I discuss the complexity of AD and possible cause-and-effect relationships between Aβ and the vascular and hemostatic systems. AD can be considered a multifactorial syndrome with various contributing pathological mechanisms. Therefore, as is routinely done with cancer, it will be important to classify patients with respect to their disease signature so that specific pathologies, including vascular pathways, can be therapeutically targeted.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29388925      PMCID: PMC5785254          DOI: 10.1172/JCI97509

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  128 in total

1.  A phase 1 study investigating DX-2930 in healthy subjects.

Authors:  Yung Chyung; Bradley Vince; Ryan Iarrobino; Dan Sexton; Jon Kenniston; Ryan Faucette; Chris TenHoor; Leslie E Stolz; Chris Stevens; Joseph Biedenkapp; Burt Adelman
Journal:  Ann Allergy Asthma Immunol       Date:  2014-06-26       Impact factor: 6.347

2.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation.

Authors:  Hirohide Asai; Seiko Ikezu; Satoshi Tsunoda; Maria Medalla; Jennifer Luebke; Tarik Haydar; Benjamin Wolozin; Oleg Butovsky; Sebastian Kügler; Tsuneya Ikezu
Journal:  Nat Neurosci       Date:  2015-10-05       Impact factor: 24.884

Review 3.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

Review 4.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

5.  Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice.

Authors:  Zu-Lin Chen; Alexey S Revenko; Pradeep Singh; A Robert MacLeod; Erin H Norris; Sidney Strickland
Journal:  Blood       Date:  2017-02-27       Impact factor: 22.113

Review 6.  Combination therapy in Alzheimer's disease: a review of current evidence.

Authors:  Beate Schmitt; Tanja Bernhardt; Hans-Juergen Moeller; Isabella Heuser; Lutz Frölich
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles.

Authors:  R Natté; M L Maat-Schieman; J Haan; M Bornebroek; R A Roos; S G van Duinen
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

8.  Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.

Authors:  Adam M Brickman; Frank A Provenzano; Jordan Muraskin; Jennifer J Manly; Sonja Blum; Zoltan Apa; Yaakov Stern; Truman R Brown; José A Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2012-12

9.  Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis.

Authors:  Alireza Atri; Suzanne B Hendrix; Vojislav Pejović; Robert K Hofbauer; John Edwards; José Luis Molinuevo; Stephen M Graham
Journal:  Alzheimers Res Ther       Date:  2015-05-18       Impact factor: 6.982

10.  Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.

Authors:  Justin Paul; Sidney Strickland; Jerry P Melchor
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  30 in total

1.  Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.

Authors:  Mario Merlini; Victoria A Rafalski; Pamela E Rios Coronado; T Michael Gill; Maya Ellisman; Gayathri Muthukumar; Keshav S Subramanian; Jae Kyu Ryu; Catriona A Syme; Dimitrios Davalos; William W Seeley; Lennart Mucke; Robert B Nelson; Katerina Akassoglou
Journal:  Neuron       Date:  2019-02-05       Impact factor: 17.173

2.  Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy.

Authors:  Pradeep K Singh; Hanna E Berk-Rauch; Nadine Soplop; Kunihiro Uryu; Sidney Strickland; Hyung Jin Ahn
Journal:  J Vis Exp       Date:  2018-11-30       Impact factor: 1.355

Review 3.  Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.

Authors:  Heeyoung Lee; EunYoung Kim
Journal:  Arch Pharm Res       Date:  2020-09-09       Impact factor: 4.946

4.  Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model.

Authors:  Marta Cortes-Canteli; Anna Kruyer; Irene Fernandez-Nueda; Ana Marcos-Diaz; Carlos Ceron; Allison T Richards; Odella C Jno-Charles; Ignacio Rodriguez; Sergio Callejas; Erin H Norris; Javier Sanchez-Gonzalez; Jesus Ruiz-Cabello; Borja Ibanez; Sidney Strickland; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2019-10-15       Impact factor: 24.094

Review 5.  Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.

Authors:  Costantino Iadecola; Marco Duering; Vladimir Hachinski; Anne Joutel; Sarah T Pendlebury; Julie A Schneider; Martin Dichgans
Journal:  J Am Coll Cardiol       Date:  2019-07-02       Impact factor: 24.094

6.  Linking late life depression and Alzheimer's disease: mechanisms and resilience.

Authors:  Sara L Weisenbach; Joseph Kim; Dustin Hammers; Kelly Konopacki; Vincent Koppelmans
Journal:  Curr Behav Neurosci Rep       Date:  2019-07-25

7.  Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients.

Authors:  Pradeep K Singh; Zu-Lin Chen; Dhiman Ghosh; Sidney Strickland; Erin H Norris
Journal:  Neurobiol Dis       Date:  2020-03-12       Impact factor: 5.996

8.  Increased Contact System Activation in Mild Cognitive Impairment Patients with Impaired Short-Term Memory.

Authors:  Pradeep K Singh; Zu-Lin Chen; Sidney Strickland; Erin H Norris
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 9.  Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.

Authors:  Klaus Grossmann
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

10.  Increasing cerebral blood flow improves cognition into late stages in Alzheimer's disease mice.

Authors:  Oliver Bracko; Brendah N Njiru; Madisen Swallow; Muhammad Ali; Mohammad Haft-Javaherian; Chris B Schaffer
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-07       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.